Stay updated on Cabozantinib in Salivary Gland Cancer: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Salivary Gland Cancer: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows that recruitment has ended with 'No longer looking for participants', signaling termination. It also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label along with a revision note to v3.6.0 (from v3.5.5).
    Difference
    0.6%
    Check dated 2026-06-12T16:47:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.5.5 is now displayed in the Study Documents section, replacing Revision: v3.5.4. This indicates a newer version of the documents or metadata on the page, and does not modify trial data or eligibility.
    Difference
    0.1%
    Check dated 2026-06-05T13:19:21.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing v3.5.3, indicating a minor update to the site's versioning. No study content or data appear to be affected.
    Difference
    0.1%
    Check dated 2026-05-15T05:51:52.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Updates the site’s displayed revision/version identifier from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:16.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision updated to v3.5.2 from v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:24:03.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. No changes to study content or eligibility criteria were made.
    Difference
    0.1%
    Check dated 2026-03-18T21:58:25.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Salivary Gland Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Salivary Gland Cancer: Clinical Trial page.